![](/img/cover-not-exists.png)
Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer
Ma, Ge, Huang, Huaxing, Li, Minghui, Li, Li, Kong, Peng, Zhu, Yichao, Xia, Tiansong, Wang, ShuiLanguage:
english
Journal:
Cancer Biomarkers
DOI:
10.3233/CBM-170986
Date:
May, 2018
File:
PDF, 6.84 MB
english, 2018